Importantly, it was shown that when Cyclophilin A levels in CD63+/TSG101+/HSP70+ EVs were combined with EBV viral capsid antigen (VCA-IgA) levels, they acted synergistically to provide a combinatorial biomarker with improved accuracy of NPC diagnosis. The gene discussed is TSG101; the disease is nasopharyngeal carcinoma.